Haleon Us Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HALEON US HOLDINGS
HALEON US HOLDINGS has thirty-one approved drugs.
There are eight US patents protecting HALEON US HOLDINGS drugs.
There are one hundred and ninety-six patent family members on HALEON US HOLDINGS drugs in thirty-two countries and fifteen supplementary protection certificates in eight countries.
Summary for Haleon Us Holdings
| International Patents: | 196 |
| US Patents: | 8 |
| Tradenames: | 28 |
| Ingredients: | 18 |
| NDAs: | 31 |
Drugs and US Patents for Haleon Us Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haleon Us Holdings | ADVIL ALLERGY SINUS | chlorpheniramine maleate; ibuprofen; pseudoephedrine hydrochloride | TABLET;ORAL | 021441-001 | Dec 19, 2002 | OTC | Yes | Yes | 7,863,287 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Haleon Us Holdings | ADVIL LIQUI-GELS | ibuprofen | CAPSULE;ORAL | 020402-001 | Apr 20, 1995 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | ADVIL PM | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 021393-001 | Dec 21, 2005 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | CHILDREN'S ADVIL | ibuprofen | SUSPENSION;ORAL | 019833-002 | Sep 19, 1989 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | JUNIOR STRENGTH ADVIL | ibuprofen | TABLET, CHEWABLE;ORAL | 020944-002 | Dec 18, 1998 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | ADVIL | ibuprofen | TABLET;ORAL | 018989-001 | May 18, 1984 | OTC | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Haleon Us Holdings | CHILDREN'S ADVIL | ibuprofen | TABLET, CHEWABLE;ORAL | 020944-001 | Dec 18, 1998 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Haleon Us Holdings
Paragraph IV (Patent) Challenges for HALEON US HOLDINGS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Capsules | 200 mg/30 mg | ➤ Subscribe | 2004-12-27 |
| ➤ Subscribe | Capsules | 60 mg | ➤ Subscribe | 2010-09-08 |
| ➤ Subscribe | Gum | 4 mg | ➤ Subscribe | 2013-01-22 |
| ➤ Subscribe | Capsules | 200 mg/38 mg | ➤ Subscribe | 2016-02-16 |
| ➤ Subscribe | Gum | 2 mg | ➤ Subscribe | 2013-01-22 |
International Patents for Haleon Us Holdings Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Portugal | 1699512 | ⤷ Start Trial |
| China | 1726035 | ⤷ Start Trial |
| United Kingdom | 0420539 | ⤷ Start Trial |
| Norway | 20064125 | ⤷ Start Trial |
| Brazil | 112021026407 | ⤷ Start Trial |
| Austria | 439884 | ⤷ Start Trial |
| Spain | 2376104 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Haleon Us Holdings Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0129748 | 98C0042 | Belgium | ⤷ Start Trial | PRODUCT NAME: ORLISTAT; REGISTRATION NO/DATE: EU/1/98/071/001 19980729 |
| 1305329 | SPC/GB08/026 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: FLUTICASONE FUROATE AND SOLVATES THEREOF; REGISTERED: UK EU/1/07/434/001 20080116; UK EU/1/07/434/002 20080116; UK EU/1/07/434/003 20080116 |
| 2506844 | 18C1022 | France | ⤷ Start Trial | PRODUCT NAME: COMBINAISON COMPRENANT UN SEL PHARMACEUTIQUEMENT ACCEPTABLE D'UMECLIDINIUM (EN PARTICULIER LE BROMURE D'UMECLIDINIUM), DU VILANTEROL OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI (EN PARTICULIER LE TRIFENATATE DE VILANTEROL), ET DU FUROATE DE FLUTICASONE; REGISTRATION NO/DATE: EU/1/17/1236 20171117 |
| 1519731 | 132013902182575 | Italy | ⤷ Start Trial | PRODUCT NAME: AZELASTINA CLORIDRATO/FLUTICASONE PROPIONATO(DYMISTA); AUTHORISATION NUMBER(S) AND DATE(S): 2011/07125-REG, 20111024;041808015/M-027/M-039/M-041/M, 20130527 |
| 0428642 | 07C0081 | France | ⤷ Start Trial | PRODUCT NAME: DOCOSANOL; REGISTRATION NO/DATE IN FRANCE: NL 33457 DU 20070821; REGISTRATION NO/DATE AT EEC: 18517 DU 20031114 |
| 2506844 | SPC/GB18/020 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: A PHARMACEUTICAL COMBINATION PRODUCT COMPRISING A PHARMACEUTICALLY ACCEPTABLE SALT OF UMECLIDINIUM (E.G. UMECLIDINIUM BROMIDE), VILANTEROL OR A PHARMACEUTICALLY ACCETPABLE SALT THEREOF (E.G. VILANTEROL TRIFENATATE), AND FLUTICASONE FUROATE; REGISTERED: UK EU/1/17/1236/001(NI) 20171117; UK EU/1/17/1236/002(NI) 20171117; UK EU/1/17/1236/003(NI) 20171117; UK PLGB 19494/0287 20171117 |
| 1781277 | PA2024501 | Lithuania | ⤷ Start Trial | PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
